Journal of Women's Health Care
Open Access

Institute for Lichen Sclerosus and Vulvar Health, The Cellular Medicine Association, Fairhope, USA

Publications

• Research Article   
  The Clitoral Injection of IncobotulinumtoxinA for the Improvement of Arousal, Orgasm & Sexual Satisfaction- A Specific Method and the Effects on Women
  Author(s): Charles Runels* and Alexandra Runnels
  
  Accepted treatments for female sexual dysfunction (FSD) are currently limited to psychological, hormonal, surgical, and psychopharmacologic interventions. There are no FDA-approved pharmaceutical interventions that directly affect the female genitalia to improve female sexual function other than prasterone for dyspareunia. Botulinum neurotoxin type A (BoNT) has been shown to improve erectile function in men by increasing arterial blood flow and possibly by increasing parasympathetic tone. In all previous studies in women, BoNT has only been used to improve sexual function by either attenuation of sensation or of muscle contraction and never to accentuate sensation, desire, orgasm, lubrication, or satisfaction directly. This pilot study was undertaken to test the effects, if any, of the clitoral injection of BoNT on female sexual function. The female sexual function index (FSFI) was us.. View More»
  DOI: 10.35248/2167-0420.24.13.715

  Abstract HTML PDF